Georgetown Lombardi Survivorship Research Initiative Seminar Series: “Improving Equitable Health Outcomes in Cancer: Catalyzing Transdisciplinary Scientific Collaborations to Transform Practice and Policy”
The Georgetown Lombardi Survivorship Research Initiative works to optimize cancer survivorship across the lifespan and ensure equity for patients of every race, ethnicity, gender and socially determined status. This seminar series will invite scientists from Georgetown and outside institutions to present their research. It will also provide a forum in which individuals may present work in progress to receive meaningful feedback from a multidisciplinary audience.
Alyce Adams, PhD, MPP
Stanford Medicine Innovation Professor
Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy)
Associate Chair for Health Equity and Community Engagement, Stanford Health Policy
Associate Director for Health Equity and Community Engagement, Stanford Cancer Institute
Associate Director, Stanford Impact Labs at Stanford University
“Improving Equitable Health Outcomes in Cancer: Catalyzing Transdisciplinary Scientific Collaborations to Transform Practice and Policy”
Meet the Professor:
Dr. Adams will speak from 10 – 11 a.m. Immediately following the SRI seminar, there will be a 30-minute Meet the Professor session, which will provide attendees an opportunity to engage in Q&A and discuss specific research subjects with Dr. Adams.
This event is co-sponsored by the Georgetown Lombardi Survivorship Research Initiative and the Georgetown Lombardi Institute for Cancer and Aging Research
About the Speaker:
Dr. Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Health Equity and Community Engagement for Stanford Health Policy, Associate Director for Health Equity and Community Engagement in the Stanford Cancer Institute, and as Associate Director for Stanford Impact Labs. Focusing on racial and socioeconomic disparities in chronic disease treatment outcomes, Dr. Adams’ interdisciplinary research seeks to evaluate the impact of changes in drug coverage policy on access to essential medications, understand the drivers of disparities in treatment adherence among insured populations, and test strategies for maximizing the benefits of treatment outcomes while minimizing harms through informed decision-making. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health Care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is a member of the Board of Directors for AcademyHealth and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality.